Karyopharm Therapeutics Inc.
看空

(Nasdaq: KPTI) Karyopharm tx "catching a falling knife"

225
Recently FDA released data suggesting KPTI and myloma medicationi was too "Toxic" their MM chemo drug had SERIOUS toxicity AEs and even DEATH. Cohort of 123 pts ~86% had some sort of serious AE and ~24% dropped out because of this. to find out more about what happened and why SP dropped, see synopsis in the link below.

Synopsis of Data can be found here- opening bell 2/25/2018:
msmoneymoves.com/


NDA application: -// Failed*
fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM631806.pdf

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。